SCHEMBL19707516

SCHEMBL19707516

CCCC(Br)C(=O)c1cccc(C)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.58
SLC6A3 Q01959 3/20 0.58
SLC6A4 P31645 2/20 0.58
TAS1R3 Q7RTX0 1/20 0.57
TAS1R1 Q7RTX1 1/20 0.57
HPGD P15428 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
PARP1 P09874 1/20 0.47
CHRNA1 P02708 1/20 0.46
CHRNG P07510 1/20 0.46
CHRNB1 P11230 1/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA4 P43681 1/20 0.46
CHRND Q07001 1/20 0.46
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19707514 0.87 TDP1 (0.51) SLC6A2SLC6A3SLC6A4TAS1R3TAS1R1
SCHEMBL634167 0.83 SLC6A2 (0.49) SLC6A2SLC6A3SLC6A4HPGDPARP1
SCHEMBL19707680 0.83 BCL2 (0.42) SLC6A2SLC6A3SLC6A4TAS1R3TAS1R1
SCHEMBL2823791 0.81 SLC6A2 (0.53) SLC6A2SLC6A3TDP1MAPTATM
SCHEMBL4935875 0.81 SLC6A2 (0.53) SLC6A2SLC6A3TDP1MAPTATM
SCHEMBL6164320 0.80 LOXL2 (0.48) SLC6A2SLC6A3SLC6A4TAS1R3TAS1R1
SCHEMBL4937398 0.80 SLC6A3 (0.54) SLC6A2SLC6A3SLC6A4HPGDTDP1
SCHEMBL13425656 0.79 PARP1 (0.57) SLC6A2SLC6A3SLC6A4TAS1R3TAS1R1
SCHEMBL19707606 0.79 TAS1R3 (0.61) TAS1R3TAS1R1ALDH1A1MEN1KMT2A
SCHEMBL19707529 0.79 GSK3B (0.66) SLC6A2SLC6A3SLC6A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017214505-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2017-12-14 WO disclosed